{"id":"https://openalex.org/W4300777986","doi":"https://doi.org/10.1093/jnci/78.4.701","title":"In Vitro Modulation of Cisplatin Cytotoxicity by Sparsomycin Inhibition of Protein Synthesis 2","display_name":"In Vitro Modulation of Cisplatin Cytotoxicity by Sparsomycin Inhibition of Protein Synthesis 2","alternate_titles":[],"publication_year":1987,"publication_date":"1987-04-01","ids":{"openalex":"https://openalex.org/W4300777986","doi":"https://doi.org/10.1093/jnci/78.4.701","mag":"1937133348","pmid":"https://pubmed.ncbi.nlm.nih.gov/3470545"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/78.4.701","doi":"https://doi.org/10.1093/jnci/78.4.701","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/78.4.701","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI: Journal of the National Cancer Institute","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4300777986"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073047612","display_name":"Zbigniew \u017bylicz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Zbigniew Zylicz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035148753","display_name":"D. J. Theo Wagener","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. J. Theo Wagener","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086018980","display_name":"Helga van Rennes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Helga van Rennes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109929742","display_name":"Johannes M.C. Wessels","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Johannes M. C. Wessels","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063110083","display_name":"Eppo van der Kleijn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eppo van der Kleijn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082823042","display_name":"Willem J. DeGrip","orcid":"https://orcid.org/0000-0001-7637-4920","observed_orcids":["https://orcid.org/0000-0001-7637-4920"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Willem J. de Grip","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110393099","display_name":"Leon A. G. M. van den Broek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Leon A. G. M. van den Broek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5057687010","display_name":"Harry C. J. Ottenheijm","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Harry C. J. Ottenheijm","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":1.7254,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.84540597,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"4","first_page":"701","last_page":"705"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.46389999985694885,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10163","display_name":"Metal complexes synthesis and properties","score":0.46389999985694885,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.14149999618530273,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10521","display_name":"RNA and protein synthesis mechanisms","score":0.09080000221729279,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sparsomycin","display_name":"sparsomycin","score":0.8899999856948853},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/protein-synthesis-inhibition","display_name":"protein synthesis inhibition","score":0.902999997138977},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.550000011920929},{"id":"https://openalex.org/keywords/cytotoxicity-potentiation","display_name":"cytotoxicity potentiation","score":0.8740000128746033},{"id":"https://openalex.org/keywords/cho-cells","display_name":"CHO cells","score":0.9509999752044678},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.7820000052452087},{"id":"https://openalex.org/keywords/leucine-incorporation","display_name":"leucine incorporation","score":0.8360000252723694},{"id":"https://openalex.org/keywords/thymidine-incorporation","display_name":"thymidine incorporation","score":0.9570000171661377},{"id":"https://openalex.org/keywords/clonogenic-survival","display_name":"clonogenic survival","score":0.8040000200271606}],"concepts":[{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.8682424426078796},{"id":"https://openalex.org/C175656101","wikidata":"https://www.wikidata.org/wiki/Q56646","display_name":"Chinese hamster ovary cell","level":3,"score":0.798763632774353},{"id":"https://openalex.org/C117262875","wikidata":"https://www.wikidata.org/wiki/Q5135057","display_name":"Clonogenic assay","level":3,"score":0.6917871832847595},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.6212579607963562},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6018723845481873},{"id":"https://openalex.org/C2777108182","wikidata":"https://www.wikidata.org/wiki/Q422464","display_name":"Thymidine","level":3,"score":0.5524941682815552},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5474775433540344},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4436720013618469},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4300300180912018},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.4176562428474426},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.27634674310684204},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20222443342208862},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1508384644985199},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.14359170198440552},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.125952810049057},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.12477430701255798}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010053","descriptor_name":"Ovary","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D013033","descriptor_name":"Sparsomycin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014176","descriptor_name":"Protein Biosynthesis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1093/jnci/78.4.701","doi":"https://doi.org/10.1093/jnci/78.4.701","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/78.4.701","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI: Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:3470545","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3470545","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Journal Article"},{"id":"mag:1937133348","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3470545","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8199999928474426,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2017430505","https://openalex.org/W66614178","https://openalex.org/W2123164670","https://openalex.org/W2505602163","https://openalex.org/W2196938964","https://openalex.org/W1535623851","https://openalex.org/W2522746455","https://openalex.org/W2009503578","https://openalex.org/W2898273645"],"abstract_inverted_index":{"Inhibition":[0],"of":[1,17,35,44,77,97,112,150,175],"protein":[2],"synthesis":[3],"can":[4],"alter":[5],"cellular":[6],"responsiveness":[7],"to":[8,23,68,121,138,180],"the":[9,33,98,107,110,173,176],"classical":[10,181],"anticancer":[11,182],"drugs.":[12,183],"The":[13,148],"in":[14,65,74,95,109],"vitro":[15],"response":[16,179],"Chinese":[18],"hamster":[19],"ovary":[20],"(CHO)":[21],"cells":[22,48,114],"cisplatin":[24,69,99],"with":[25,32,49,135],"or":[26,55,142],"without":[27],"sparsomycin":[28],"(Sm)":[29],"was":[30,106,125],"studied":[31],"use":[34],"[3H]leucine":[36,59,81],"and":[37,40,63,82,90,93,133,153],"[methyl-3H]thymidine":[38,83],"incorporation":[39,60,84],"clonogenic":[41],"assay.":[42],"Pretreatment":[43],"exponentially":[45],"growing":[46],"CHO":[47],"1":[50],"microgram":[51],"Sm/ml":[52],"for":[53,169],"3":[54,86],"5":[56],"hours":[57,87],"decreased":[58],"by":[61,88],"20%":[62],"resulted":[64,94],"significant":[66],"resistance":[67],"(P":[70,101,115],"=":[71,102,116],".005).":[72],"Sm":[73,122,136,164],"a":[75,166],"concentration":[76],"10":[78],"micrograms/ml":[79],"reduced":[80],"after":[85],"92":[89],"84%,":[91],"respectively,":[92],"potentiation":[96,154],"cytotoxicity":[100],".004).":[103],"This":[104],"effect":[105,145],"same":[108],"case":[111],"nonproliferating":[113],".005),":[117],"while":[118],"protection":[119,152],"due":[120],"(1":[123],"microgram/ml)":[124],"seen":[126],"only":[127],"during":[128],"cell":[129,178],"proliferation.":[130],"Simultaneous":[131],"incubation":[132],"postincubation":[134],"proved":[137],"have":[139],"much":[140],"less":[141],"no":[143],"potentiating":[144],"on":[146,172],"cisplatin.":[147],"mechanisms":[149],"both":[151],"are":[155],"still":[156],"not":[157],"clear,":[158],"but":[159],"our":[160],"data":[161],"indicate":[162],"that":[163],"is":[165],"promising":[167],"drug":[168],"further":[170],"studies":[171],"modulation":[174],"cancer":[177]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4300777986","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-10-04T00:00:00"}
